Latest News and Press Releases
Want to stay updated on the latest news?
-
New York, Oct. 12, 2023 (GLOBE NEWSWIRE) -- In 2022, the global revenue generated by the Rheumatoid Arthritis Market amounted to approximately US$ 687.9 Million. Forecasts indicate that the...
-
PrismRA® first-of-its-kind molecular signature test validated in Ambry’s central laboratory.Partnership provides infrastructure for rapid scaling and patient accessibility. WALTHAM, Mass. and...
-
New York, June 18, 2018 (GLOBE NEWSWIRE) -- Persistence Market Research has come up with revised forecasts on the global rheumatoid arthritis diagnosis test market. According to this latest market...